A. ATİLLA Et Al. , "Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases," Journal of Microbiology and Infectious Diseases , vol.5, no.4, pp.151-155, 2015
ATİLLA, A. Et Al. 2015. Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases. Journal of Microbiology and Infectious Diseases , vol.5, no.4 , 151-155.
ATİLLA, A., KILIÇ, S. S., BOSTANCI, F., & DUYAR, E., (2015). Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases. Journal of Microbiology and Infectious Diseases , vol.5, no.4, 151-155.
ATİLLA, Aynur Et Al. "Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases," Journal of Microbiology and Infectious Diseases , vol.5, no.4, 151-155, 2015
ATİLLA, Aynur Et Al. "Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases." Journal of Microbiology and Infectious Diseases , vol.5, no.4, pp.151-155, 2015
ATİLLA, A. Et Al. (2015) . "Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases." Journal of Microbiology and Infectious Diseases , vol.5, no.4, pp.151-155.
@article{article, author={Aynur Atilla Et Al. }, title={Pegylated Interferon/Ribavirin dual therapy in patients with chronic Hepatitis C: results of 323 cases}, journal={Journal of Microbiology and Infectious Diseases}, year=2015, pages={151-155} }